ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 330 filers reported holding ARGENX SE in Q2 2024. The put-call ratio across all filers is 1.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $387,896 | +10.2% | 902 | +0.9% | 0.00% | 0.0% |
| Q1 2024 | $351,986 | -5.4% | 894 | -8.6% | 0.00% | 0.0% |
| Q4 2023 | $372,061 | -18.6% | 978 | +5.2% | 0.00% | -20.0% |
| Q3 2023 | $457,216 | +26.6% | 930 | +0.3% | 0.01% | +25.0% |
| Q2 2023 | $361,280 | +7.6% | 927 | +2.9% | 0.00% | 0.0% |
| Q1 2023 | $335,695 | -3.5% | 901 | -1.9% | 0.00% | 0.0% |
| Q4 2022 | $347,766 | +1.7% | 918 | -5.4% | 0.00% | 0.0% |
| Q3 2022 | $342,000 | -2.6% | 970 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $351,000 | – | 926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |